Pfizer
ORIC icon

Pfizer’s Oric Pharmaceuticals ORIC Stock Holding History

Pfizer’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.91M Hold
372,904
– – 2.99% 9
2026
Q2 		$3.55M Sell
372,904
-4,407,497
-92% -$40M 2.09% 10
2026
Q1 		$57.7M Sell
4,780,401
-595,943
-11% -$6.77M 24.14% 1
2025
Q4 		$44M Hold
5,376,344
– – 18.6% 1
2025
Q3 		$64.5M Hold
5,376,344
– – 14.75% 2
2025
Q2 		$54.6M Hold
5,376,344
– – 9.47% 2
2025
Q1 		$30M Hold
5,376,344
– – 5.99% 3
2024
Q4 		$43.4M Buy
+5,376,344
New +$49.3M 1.67% 5

Other funds holding ORIC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Pfizer's ORIC Position: Q3 2026 in Review

Pfizer held its Oric Pharmaceuticals (ORIC) position steady in Q3 2026 at 372,904 shares worth $4.91M. The position accounts for 2.99% of the portfolio, ranked #9.

Pfizer first reported a position in ORIC in Q4 2024 and has held it in 8 quarters since. The position peaked at $64.5M in Q3 2025. 124 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Pfizer held 372,904 shares of Oric Pharmaceuticals worth $4.91M as of Q3 2026.
  • Pfizer left its Oric Pharmaceuticals share count unchanged in Q3 2026.
  • Oric Pharmaceuticals made up 2.99% of Pfizer's portfolio in Q3 2026, its #9 holding.
  • Pfizer first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Pfizer's Oric Pharmaceuticals position peaked at $64.5M in Q3 2025.
  • 124 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Pfizer's 13F filing for Q3 2026, filed 12 Nov 2026.